Growth Metrics

TELA Bio (TELA) Shares Outstanding (Diluted Average) (2019 - 2025)

TELA Bio has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $46.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $46.9 million for Q4 2025, up 64.58% from a year ago — trailing twelve months through Dec 2025 was $46.9 million (up 64.58% YoY), and the annual figure for FY2025 was $46.9 million, up 64.58%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $46.9 million at TELA Bio, up from $45.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for TELA hit a ceiling of $46.9 million in Q4 2025 and a floor of $14.4 million in Q1 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $21.8 million (2023), compared with a mean of $24.5 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 0.69% in 2022 and later surged 84.17% in 2025.
  • TELA Bio's Shares Outstanding (Diluted Average) stood at $14.5 million in 2021, then increased by 12.4% to $16.3 million in 2022, then soared by 40.58% to $22.9 million in 2023, then rose by 24.74% to $28.5 million in 2024, then soared by 64.58% to $46.9 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $46.9 million (Q4 2025), $45.4 million (Q3 2025), and $45.3 million (Q2 2025) per Business Quant data.